• Digoxin in Translational Research: Beyond Cardiac and Antivi

  2026-07-14

  Explore how Digoxin, a potent Na+/K+ ATPase pump inhibitor, enables innovative cross-domain research in cardiac and viral models. This article uniquely examines translational implications, protocol nuances, and comparative insights, offering depth beyond standard assay guidance.

• Mycophenolic Acid as a Dehydrogenase Inhibitor in Immunometa

  2026-07-14

  Harness Mycophenolic acid for precise immunometabolic modulation in whole-blood assays, enabling reproducible cytokine profiling and metabolic intervention studies. This article translates the latest protocol breakthroughs and troubleshooting strategies into actionable steps, giving researchers a competitive edge in immune response analysis.

• Apicidin as a Histone Deacetylase Inhibitor: Protocols & Pit

  2026-07-13

  Apicidin stands out as a highly selective histone deacetylase inhibitor, enabling researchers to probe epigenetic regulation across oncology, toxicology, and developmental biology. Learn how to harness Apicidin in experimental workflows, optimize protocols, and navigate unique troubleshooting challenges—powered by cutting-edge evidence and practical tips.

• Reversine: Practical Protocols for Aurora Kinase Inhibition

  2026-07-13

  Reversine is a nanomolar-potency Aurora kinase inhibitor for dissecting mitotic control, apoptosis induction, and cancer cell proliferation inhibition in research settings. It is best suited for in vitro and in vivo studies targeting Aurora kinases A, B, and C, especially in cervical cancer models. Not intended for clinical, diagnostic, or therapeutic use.

• Cholesterol’s Pivotal Role in mRNA-LNP Therapy Design

  2026-07-12

  Explore how cholesterol, the principal sterol, underpins advanced mRNA–lipid nanoparticle (LNP) therapeutics. This article reveals unique biophysical and translational insights for lipid metabolism research, with a focus on precision engineering for localized cancer therapy.

• Intravesical p21 mRNA–LNP Therapy: Bladder Cancer Breakthrou

  2026-07-10

  The referenced study introduces a non-viral, localized mRNA therapy for bladder cancer by delivering p21 mRNA via lipid nanoparticles directly into the bladder. This approach achieves targeted tumor suppressor restoration, significantly inhibiting tumor growth, and suggests a new therapeutic paradigm for non-muscle-invasive bladder cancer.

• Angiotensin II in Neurovascular and Vascular Remodeling Rese

  2026-07-09

  Explore the multifaceted role of Angiotensin II in neurovascular signaling, vascular smooth muscle cell hypertrophy research, and advanced cardiovascular models. This article uniquely bridges neurodegeneration and vascular pathology, offering new insight for translational assay design.

• MDL 28170 Calpain Inhibitor: Advanced Neuroprotection Workfl

  2026-07-09

  MDL 28170 stands out as a selective calpain and cathepsin B inhibitor, enabling precise neuroprotection research and translational modeling. Its rapid blood-brain barrier penetration and proven restoration of synaptic plasticity make it a versatile tool for cognitive, ischemic, and anti-parasitic experimental pipelines.

• Ziprasidone HCl: Optimizing Neuroscience and Oncology Assays

  2026-07-08

  Ziprasidone Hydrochloride empowers researchers with reliable, dual-domain workflows for both dopaminergic signaling research and advanced cancer metabolism studies. This guide delivers protocol-driven insights, troubleshooting strategies, and unique advantages for reproducible results using APExBIO’s high-quality reagent.

• Controlling Lipid Nanoparticle Size for Optimized mRNA Expre

  2026-07-08

  This study demonstrates how precise adjustments in manufacturing conditions—specifically the aqueous-to-lipid phase ratio—enable fine control over lipid nanoparticle (LNP) size, directly impacting mRNA delivery efficacy. The findings clarify how LNP dimension modulates both in vitro and in vivo mRNA expression, informing rational design of LNP-based therapeutics.

• Cholesterol in Cellular Membrane Engineering and In Vitro Th

  2026-07-07

  Explore the principal sterol, cholesterol, as a foundational molecule for advanced membrane engineering and in vitro therapeutic development. This article provides a unique, scientifically in-depth perspective on cholesterol’s mechanistic roles and assay implications, setting it apart from existing content.

• One-step TUNEL Cy3 Kit: High-Specificity Apoptosis Detection

  2026-07-07

  The One-step TUNEL Cy3 Apoptosis Detection Kit enables sensitive, single-step detection of DNA fragmentation in apoptosis research. Its terminal deoxynucleotidyl transferase (TdT) labeling mechanism is validated for use in tissue sections and cultured cells, delivering reproducible, quantitative results. This dossier examines its mechanism, evidence base, and practical limitations.

• Fingolimod (FTY720): Protocols and Troubleshooting for In Vi

  2026-07-06

  Fingolimod (FTY720) is redefining immune modulation beyond multiple sclerosis, now empowering in vivo T cell engineering for advanced tumor immunotherapy. This guide delivers hands-on protocols, troubleshooting insights, and data-driven strategies for leveraging APExBIO’s high-purity Fingolimod in translational research.

• Flumequine (SKU B2292): Precision in DNA Topoisomerase II In

  2026-07-06

  This article addresses real laboratory challenges in in vitro cell viability and cytotoxicity assays, focusing on how Flumequine (SKU B2292) elevates reproducibility and assay fidelity. Through scenario-driven Q&A, we highlight best practices for topoisomerase II inhibition assays and justify the evidence-backed selection of Flumequine for DNA replication research.

• PDHA1 Succinylation-Driven α-KGA Accumulation and Immune Sup

  2026-07-05

  This study uncovers how succinylation of PDHA1 at lysine 83 in cholangiocarcinoma remodels tumor metabolism, leading to α-ketoglutarate (α-KGA) buildup that suppresses macrophage antigen presentation. The findings highlight a novel metabolic-immune axis and suggest that targeting PDHA1 succinylation may sensitize tumors to chemotherapy.

485 records 7/33 page Previous Next First page 上5页 678910 下5页 Last page